140 related articles for article (PubMed ID: 18726146)
1. Host immune response in B-cell lymphomas: friend or foe?
Juszczyński P; Nowak J; Warzocha K
Arch Immunol Ther Exp (Warsz); 2008; 56(4):245-55. PubMed ID: 18726146
[TBL] [Abstract][Full Text] [Related]
2. Eradication of established B-cell lymphoma by CD19-specific murine T cells is dependent on host lymphopenic environment and can be mediated by CD4+ and CD8+ T cells.
Cheadle EJ; Hawkins RE; Batha H; Rothwell DG; Ashton G; Gilham DE
J Immunother; 2009 Apr; 32(3):207-18. PubMed ID: 19242379
[TBL] [Abstract][Full Text] [Related]
3. The immune system--is it relevant to cancer development, progression and treatment?
Prestwich RJ; Errington F; Hatfield P; Merrick AE; Ilett EJ; Selby PJ; Melcher AA
Clin Oncol (R Coll Radiol); 2008 Mar; 20(2):101-12. PubMed ID: 18037277
[TBL] [Abstract][Full Text] [Related]
4. Immunomodulation and lymphoma in humans.
Ponce RA; Gelzleichter T; Haggerty HG; Heidel S; Holdren MS; Lebrec H; Mellon RD; Pallardy M
J Immunotoxicol; 2014; 11(1):1-12. PubMed ID: 23746314
[TBL] [Abstract][Full Text] [Related]
5. Th2-mediated anti-tumour immunity: friend or foe?
Ellyard JI; Simson L; Parish CR
Tissue Antigens; 2007 Jul; 70(1):1-11. PubMed ID: 17559575
[TBL] [Abstract][Full Text] [Related]
6. Cancer immunoediting from immune surveillance to immune escape.
Kim R; Emi M; Tanabe K
Immunology; 2007 May; 121(1):1-14. PubMed ID: 17386080
[TBL] [Abstract][Full Text] [Related]
7. Natural immunity to cancer in humans.
Bindea G; Mlecnik B; Fridman WH; Pagès F; Galon J
Curr Opin Immunol; 2010 Apr; 22(2):215-22. PubMed ID: 20207124
[TBL] [Abstract][Full Text] [Related]
8. Chronic hepatitis C in the advanced adult and elderly subjects.
Gattoni A; Parlato A; Vangieri B; Bresciani M; Petraccaro M
Minerva Gastroenterol Dietol; 2009 Jun; 55(2):145-57. PubMed ID: 19305374
[TBL] [Abstract][Full Text] [Related]
9. Structural immunology and crystallography help immunologists see the immune system in action: how T and NK cells touch their ligands.
Chen Y; Shi Y; Cheng H; An YQ; Gao GF
IUBMB Life; 2009 Jun; 61(6):579-90. PubMed ID: 19472182
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies.
Li B; Simmons A; Du T; Lin C; Moskalenko M; Gonzalez-Edick M; VanRoey M; Jooss K
Clin Immunol; 2009 Nov; 133(2):184-97. PubMed ID: 19664962
[TBL] [Abstract][Full Text] [Related]
11. The immunobiology of cancer immunosurveillance and immunoediting.
Dunn GP; Old LJ; Schreiber RD
Immunity; 2004 Aug; 21(2):137-48. PubMed ID: 15308095
[TBL] [Abstract][Full Text] [Related]
12. The role of the immune system in early epithelial carcinogenesis: B-ware the double-edged sword.
Houghton AN; Uchi H; Wolchok JD
Cancer Cell; 2005 May; 7(5):403-5. PubMed ID: 15894259
[TBL] [Abstract][Full Text] [Related]
13. Secretion of tumor-specific antigen by myeloma cells is required for cancer immunosurveillance by CD4+ T cells.
Corthay A; Lundin KU; Lorvik KB; Hofgaard PO; Bogen B
Cancer Res; 2009 Jul; 69(14):5901-7. PubMed ID: 19567679
[TBL] [Abstract][Full Text] [Related]
14. Clinical applications of rituximab in allogeneic stem cell transplantation: anti-tumor and immunomodulatory effects.
Ratanatharathorn V; Pavletic S; Uberti JP
Cancer Treat Rev; 2009 Dec; 35(8):653-61. PubMed ID: 19682801
[TBL] [Abstract][Full Text] [Related]
15. Endogenous IL-21 restricts CD8+ T cell expansion and is not required for tumor immunity.
Søndergaard H; Coquet JM; Uldrich AP; McLaughlin N; Godfrey DI; Sivakumar PV; Skak K; Smyth MJ
J Immunol; 2009 Dec; 183(11):7326-36. PubMed ID: 19915059
[TBL] [Abstract][Full Text] [Related]
16. Aspects of B-cell non-Hodgkin's lymphoma development: a transition from immune-reactivity to malignancy.
Illes A; Varoczy L; Papp G; Wilson PC; Alex P; Jonsson R; Kovacs T; Konttinen YT; Zeher M; Nakken B; Szodoray P
Scand J Immunol; 2009 May; 69(5):387-400. PubMed ID: 19508370
[TBL] [Abstract][Full Text] [Related]
17. Tumor-educated CD11bhighIalow regulatory dendritic cells suppress T cell response through arginase I.
Liu Q; Zhang C; Sun A; Zheng Y; Wang L; Cao X
J Immunol; 2009 May; 182(10):6207-16. PubMed ID: 19414774
[TBL] [Abstract][Full Text] [Related]
18. The lack of epithelial interleukin-7 and BAFF/BLyS gene expression in prostate cancer as a possible mechanism of tumor escape from immunosurveillance.
Di Carlo E; D'Antuono T; Pompa P; Giuliani R; Rosini S; Stuppia L; Musiani P; Sorrentino C
Clin Cancer Res; 2009 May; 15(9):2979-87. PubMed ID: 19366834
[TBL] [Abstract][Full Text] [Related]
19. The emerging concept of antigen-driven lymphomas: epidemiology and treatment implications.
Fisher SG; Fisher RI
Curr Opin Oncol; 2006 Sep; 18(5):417-24. PubMed ID: 16894287
[TBL] [Abstract][Full Text] [Related]
20. Host response to colorectal cancer.
Salama P; Platell C
ANZ J Surg; 2008 Sep; 78(9):745-53. PubMed ID: 18844901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
